CRNX
Price
$27.88
Change
-$0.65 (-2.28%)
Updated
Aug 7 closing price
Capitalization
2.61B
90 days until earnings call
IMTX
Price
$6.32
Change
-$0.02 (-0.32%)
Updated
Aug 7 closing price
Capitalization
771.24M
4 days until earnings call
Interact to see
Advertisement

CRNX vs IMTX

Header iconCRNX vs IMTX Comparison
Open Charts CRNX vs IMTXBanner chart's image
Crinetics Pharmaceuticals
Price$27.88
Change-$0.65 (-2.28%)
Volume$1.07M
Capitalization2.61B
Immatics
Price$6.32
Change-$0.02 (-0.32%)
Volume$329.89K
Capitalization771.24M
CRNX vs IMTX Comparison Chart in %
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. IMTX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and IMTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (CRNX: $27.88 vs. IMTX: $6.34)
Brand notoriety: CRNX and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 149% vs. IMTX: 58%
Market capitalization -- CRNX: $2.61B vs. IMTX: $771.24M
CRNX [@Biotechnology] is valued at $2.61B. IMTX’s [@Biotechnology] market capitalization is $771.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMTX is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 4 TA indicator(s) are bullish while IMTX’s TA Score has 2 bullish TA indicator(s).

  • CRNX’s TA Score: 4 bullish, 6 bearish.
  • IMTX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than IMTX.

Price Growth

CRNX (@Biotechnology) experienced а -2.48% price change this week, while IMTX (@Biotechnology) price change was -1.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

CRNX is expected to report earnings on Nov 06, 2025.

IMTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.61B) has a higher market cap than IMTX($771M). IMTX YTD gains are higher at: -10.759 vs. CRNX (-45.472). IMTX has higher annual earnings (EBITDA): -4.49M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. IMTX (544M). IMTX has less debt than CRNX: IMTX (18.4M) vs CRNX (50.8M). IMTX has higher revenues than CRNX: IMTX (144M) vs CRNX (760K).
CRNXIMTXCRNX / IMTX
Capitalization2.61B771M339%
EBITDA-373.49M-4.49M8,320%
Gain YTD-45.472-10.759423%
P/E RatioN/A27.61-
Revenue760K144M1%
Total Cash1.27B544M234%
Total Debt50.8M18.4M276%
FUNDAMENTALS RATINGS
CRNX vs IMTX: Fundamental Ratings
CRNX
IMTX
OUTLOOK RATING
1..100
5619
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
9692
PRICE GROWTH RATING
1..100
8343
P/E GROWTH RATING
1..100
10067
SEASONALITY SCORE
1..100
2637

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMTX's Valuation (60) in the null industry is in the same range as CRNX (92) in the Pharmaceuticals Major industry. This means that IMTX’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (70) in the Pharmaceuticals Major industry is in the same range as IMTX (100) in the null industry. This means that CRNX’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's SMR Rating (92) in the null industry is in the same range as CRNX (96) in the Pharmaceuticals Major industry. This means that IMTX’s stock grew similarly to CRNX’s over the last 12 months.

IMTX's Price Growth Rating (43) in the null industry is somewhat better than the same rating for CRNX (83) in the Pharmaceuticals Major industry. This means that IMTX’s stock grew somewhat faster than CRNX’s over the last 12 months.

IMTX's P/E Growth Rating (67) in the null industry is somewhat better than the same rating for CRNX (100) in the Pharmaceuticals Major industry. This means that IMTX’s stock grew somewhat faster than CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXIMTX
RSI
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 18 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIVVX22.63N/A
N/A
Causeway International Value Inv
DBOZX24.85N/A
N/A
BNY Mellon Balanced Opportunity Z
CCVAX31.98N/A
N/A
Calvert Small-Cap A
CCTRX12.55N/A
N/A
Columbia Small Cap Value II R
CRFCX11.40N/A
N/A
Calvert Focused Value C

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-2.28%
XNCR - CRNX
62%
Loosely correlated
-2.27%
IDYA - CRNX
57%
Loosely correlated
-5.16%
RVMD - CRNX
56%
Loosely correlated
-4.69%
TRDA - CRNX
55%
Loosely correlated
-10.92%
SYRE - CRNX
55%
Loosely correlated
-4.51%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+0.08%
IDYA - IMTX
50%
Loosely correlated
-5.16%
OCUL - IMTX
50%
Loosely correlated
-1.60%
RGNX - IMTX
50%
Loosely correlated
-4.01%
DAWN - IMTX
48%
Loosely correlated
+3.97%
CRNX - IMTX
48%
Loosely correlated
-2.28%
More